Literature DB >> 9819387

Regulation of RasGRP via a phorbol ester-responsive C1 domain.

C E Tognon1, H E Kirk, L A Passmore, I P Whitehead, C J Der, R J Kay.   

Abstract

As part of a cDNA library screen for clones that induce transformation of NIH 3T3 fibroblasts, we have isolated a cDNA encoding the murine homolog of the guanine nucleotide exchange factor RasGRP. A point mutation predicted to prevent interaction with Ras abolished the ability of murine RasGRP (mRasGRP) to transform fibroblasts and to activate mitogen-activated protein kinases (MAP kinases). MAP kinase activation via mRasGRP was enhanced by coexpression of H-, K-, and N-Ras and was partially suppressed by coexpression of dominant negative forms of H- and K-Ras. The C terminus of mRasGRP contains a pair of EF hands and a C1 domain which is very similar to the phorbol ester- and diacylglycerol-binding C1 domains of protein kinase Cs. The EF hands could be deleted without affecting the ability of mRasGRP to transform NIH 3T3 cells. In contrast, deletion of the C1 domain or an adjacent cluster of basic amino acids eliminated the transforming activity of mRasGRP. Transformation and MAP kinase activation via mRasGRP were restored if the deleted C1 domain was replaced either by a membrane-localizing prenylation signal or by a diacylglycerol- and phorbol ester-binding C1 domain of protein kinase C. The transforming activity of mRasGRP could be regulated by phorbol ester when serum concentrations were low, and this effect of phorbol ester was dependent on the C1 domain of mRasGRP. The C1 domain could also confer phorbol myristate acetate-regulated transforming activity on a prenylation-defective mutant of K-Ras. The C1 domain mediated the translocation of mRasGRP to cell membranes in response to either phorbol ester or serum stimulation. These results suggest that the primary mechanism of activation of mRasGRP in fibroblasts is through its recruitment to diacylglycerol-enriched membranes. mRasGRP is expressed in lymphoid tissues and the brain, as well as in some lymphoid cell lines. In these cells, RasGRP has the potential to serve as a direct link between receptors which stimulate diacylglycerol-generating phospholipase Cs and the activation of Ras.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9819387      PMCID: PMC109282          DOI: 10.1128/MCB.18.12.6995

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  63 in total

Review 1.  SH3 domains. Minding your p's and q's.

Authors:  B J Mayer; M J Eck
Journal:  Curr Biol       Date:  1995-04-01       Impact factor: 10.834

2.  The Grb2 binding domain of mSos1 is not required for downstream signal transduction.

Authors:  W Wang; E M Fisher; Q Jia; J M Dunn; E Porfiri; J Downward; S E Egan
Journal:  Nat Genet       Date:  1995-07       Impact factor: 38.330

3.  Sos, Vav, and C3G participate in B cell receptor-induced signaling pathways and differentially associate with Shc-Grb2, Crk, and Crk-L adaptors.

Authors:  L Smit; G van der Horst; J Borst
Journal:  J Biol Chem       Date:  1996-04-12       Impact factor: 5.157

4.  Calcium activation of Ras mediated by neuronal exchange factor Ras-GRF.

Authors:  C L Farnsworth; N W Freshney; L B Rosen; A Ghosh; M E Greenberg; L A Feig
Journal:  Nature       Date:  1995-08-10       Impact factor: 49.962

Review 5.  Guanine nucleotide exchange factors: activators of the Ras superfamily of proteins.

Authors:  L A Quilliam; R Khosravi-Far; S Y Huff; C J Der
Journal:  Bioessays       Date:  1995-05       Impact factor: 4.345

6.  Shc adaptor proteins are key transducers of mitogenic signaling mediated by the G protein-coupled thrombin receptor.

Authors:  Y Chen; D Grall; A E Salcini; P G Pelicci; J Pouysségur; E Van Obberghen-Schilling
Journal:  EMBO J       Date:  1996-03-01       Impact factor: 11.598

7.  Identification of Rap1 as a target for the Crk SH3 domain-binding guanine nucleotide-releasing factor C3G.

Authors:  T Gotoh; S Hattori; S Nakamura; H Kitayama; M Noda; Y Takai; K Kaibuchi; H Matsui; O Hatase; H Takahashi
Journal:  Mol Cell Biol       Date:  1995-12       Impact factor: 4.272

8.  Catalytic activity of the mouse guanine nucleotide exchanger mSOS is activated by Fyn tyrosine protein kinase and the T-cell antigen receptor in T cells.

Authors:  B Li; M Subleski; N Fusaki; T Yamamoto; T Copeland; G L Princler; H Kung; T Kamata
Journal:  Proc Natl Acad Sci U S A       Date:  1996-02-06       Impact factor: 11.205

9.  A comparison of the interaction of Shc and the tyrosine kinase ZAP-70 with the T cell antigen receptor zeta chain tyrosine-based activation motif.

Authors:  N Osman; S C Lucas; H Turner; D Cantrell
Journal:  J Biol Chem       Date:  1995-06-09       Impact factor: 5.157

10.  Expression of Thy-1 on human hematopoietic progenitor cells.

Authors:  W Craig; R Kay; R L Cutler; P M Lansdorp
Journal:  J Exp Med       Date:  1993-05-01       Impact factor: 14.307

View more
  57 in total

Review 1.  Regulation of hematopoietic cell development and activation by adapter proteins.

Authors:  Gary A Koretzky; Farhad Abtahian; Geo S Derimanov; Sally A Dmowski; Anastasia Guerriero; Martha S Jordan; Jonathan S Maltzman; Benjamin A Olenchock; Andrew L Singer; Jennifer N Wu; Xiao-Ping Zhong
Journal:  Immunol Res       Date:  2003       Impact factor: 2.829

2.  Identification of a Ras GTPase-activating protein regulated by receptor-mediated Ca2+ oscillations.

Authors:  Simon A Walker; Sabine Kupzig; Dalila Bouyoucef; Louise C Davies; Takashi Tsuboi; Trever G Bivona; Gyles E Cozier; Peter J Lockyer; Alan Buckler; Guy A Rutter; Maxine J Allen; Mark R Philips; Peter J Cullen
Journal:  EMBO J       Date:  2004-04-01       Impact factor: 11.598

3.  Differential regulation of primary and memory CD8 T cell immune responses by diacylglycerol kinases.

Authors:  Jinwook Shin; Thomas F O'Brien; Jason M Grayson; Xiao-Ping Zhong
Journal:  J Immunol       Date:  2012-01-23       Impact factor: 5.422

4.  Farnesyltransferase inhibitor tipifarnib inhibits Rheb prenylation and stabilizes Bax in acute myelogenous leukemia cells.

Authors:  Husheng Ding; Jennifer S McDonald; Seongseok Yun; Paula A Schneider; Kevin L Peterson; Karen S Flatten; David A Loegering; Ann L Oberg; Shaun M Riska; Shengbing Huang; Frank A Sinicrope; Alex A Adjei; Judith E Karp; X Wei Meng; Scott H Kaufmann
Journal:  Haematologica       Date:  2013-08-30       Impact factor: 9.941

5.  Nucleocytoplasmic trafficking of the Syk protein tyrosine kinase.

Authors:  Fei Zhou; Jianjie Hu; Haiyan Ma; Marietta L Harrison; Robert L Geahlen
Journal:  Mol Cell Biol       Date:  2006-05       Impact factor: 4.272

6.  RasGRP3 contributes to formation and maintenance of the prostate cancer phenotype.

Authors:  Dazhi Yang; Noemi Kedei; Luowei Li; Juan Tao; Julia F Velasquez; Aleksandra M Michalowski; Balázs I Tóth; Rita Marincsák; Attila Varga; Tamás Bíró; Stuart H Yuspa; Peter M Blumberg
Journal:  Cancer Res       Date:  2010-09-28       Impact factor: 12.701

7.  The ζ isoform of diacylglycerol kinase plays a predominant role in regulatory T cell development and TCR-mediated ras signaling.

Authors:  Rohan P Joshi; Amanda M Schmidt; Jayajit Das; Dariusz Pytel; Matthew J Riese; Melissa Lester; J Alan Diehl; Edward M Behrens; Taku Kambayashi; Gary A Koretzky
Journal:  Sci Signal       Date:  2013-11-26       Impact factor: 8.192

8.  A vascular gene trap screen defines RasGRP3 as an angiogenesis-regulated gene required for the endothelial response to phorbol esters.

Authors:  David M Roberts; Amanda L Anderson; Michihiro Hidaka; Raymond L Swetenburg; Cam Patterson; William L Stanford; Victoria L Bautch
Journal:  Mol Cell Biol       Date:  2004-12       Impact factor: 4.272

9.  Overcoming amino-Nogo-induced inhibition of cell spreading and neurite outgrowth by 12-O-tetradecanoylphorbol-13-acetate-type tumor promoters.

Authors:  Kangwen Deng; Ying Gao; Zixuan Cao; Edmund I Graziani; Andrew Wood; Patrick Doherty; Frank S Walsh
Journal:  J Biol Chem       Date:  2009-12-15       Impact factor: 5.157

10.  Role of protein kinase C delta in reactivation of Kaposi's sarcoma-associated herpesvirus.

Authors:  Einat Deutsch; Adina Cohen; Gila Kazimirsky; Sara Dovrat; Hadara Rubinfeld; Chaya Brodie; Ronit Sarid
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.